Roche Holding (RHHBY)
(Delayed Data from OTC)
$30.25 USD
+0.23 (0.77%)
Updated Apr 26, 2024 04:00 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Earnings News For RHHBY
-
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
-
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
-
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
-
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
-
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
-
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
-
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
-
Roche (RHHBY) 1H22 Earnings, Sales Grow, View Disappoints
-
Roche's (RHHBY) Q1 Sales Grow on COVID-19 Tests, New Drugs
-
Roche's (RHHBY) 2021 Earnings, Sales Grow on COVID-19 Tests
-
Roche (RHHBY) 9M21 Sales Grow on Strong COVID-19 Tests, View Up
-
Roche's (RHHBY) 1H21 Sales Rise Despite Impact of Biosimilars
-
Roche (RHHBY) 2020 Earnings Down Due to Biosimilars, COVID-19
-
Roche's (RHHBY) 9M20 Sales Affected by COVID-19 Outbreak